Science

Feb 15, 2025, 10:35

Myeloma Paper of the Day, February 15th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Final analysis of MAIA patient-reported outcomes finds sustained Improvement in health-related quality of life in transplant-ineligible newly diagnosed myeloma treated with daratumumab/len/dex vs. len/dex doublet.”

“Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient-Reported Outcomes”

Authors: Aurore Perrot, Thierry Facon, Torben Plesner, Fredrik Borgsten, Katja Weisel et al.

More posts featuring Robert Orlowski.

Aurore Perrot cancer Fredrik Borgsten Katja Weisel multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Thierry Facon Torben Plesner

Oncologist Near Me - Douglas Flora: Pioneering AI Integration in Cancer Care

Douglas Hanahan was Honored with the 2025 Pezcoller Foundation-AACR International Award for Extraordinary Cancer Research

Bente Mikkelsen Appointed as Director of Global Engagement Strategies at St. Jude Children's Research Hospital

Audrey Evans - mother of neuroblastoma, a force for good in the world

New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer